We are proud to announce that Humaira Qureshi, President of Qinecsa Solutions, has been featured in the September 2024 issue of the DIA Global Forum. In her article, titled “A New Pharmacovigilance Ecosystem: Automation, AI, and Continuous Improvement,” Humaira explores the evolution of pharmacovigilance (PV) as it transforms from a reactive, safety-focused function into a proactive, value-creating element within the life sciences industry.
The article delves into the increasing importance of automation and AI in handling high volumes of data, meeting the demands of complex clinical trials, and driving faster commercialization. These technologies are essential to shaping the future of drug safety, but as Humaira emphasizes, the success of these advancements requires more than just tools—it depends on cultural shifts, strong leadership, and the implementation of adaptive systems that can support continuous improvement.
Key Highlights of the Article:
- The integration of automation and AI into PV processes to increase efficiency and eliminate human error.
- How the future of PV depends on building a strong foundation of leadership, culture, and processes that support technology adoption.
- A case study on the role of cognitive robotic process automation in standardizing safety surveillance for a top pharmaceutical company.
As the industry continues to innovate, Humaira’s insights emphasize the importance of preparing for a flexible, scalable PV system that leverages technology to enhance patient safety and process efficiency.
For inquiries, please reach out to [email protected]
Qinecsa Solutions is dedicated to providing top-tier pharmacovigilance technology and scientific expertise, connecting life science companies with the right safety solutions.
